ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1124

CD4+ Cytotoxic T Lymphocytes (CTL) Are Present in Sjögren’s Disease Minor Salivary Glands and Associate with Markers of Epithelial Cell Damage near Infiltrates

Michelle Joachims1, Chuang Li1, Joshua Rusbuldt2, Ben Fowler1, Astrid Rasmussen1, Kiely Grundahl1, R. Hal Scofield3, Kathy Sivils4, Christopher Lessard1 and A. Darise Farris1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA, 3University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Janssen Research and Development, LLC, Spring House, PA

Meeting: ACR Convergence 2022

Keywords: Cytotoxic Cells, Genomics and Proteomics, Sjögren's syndrome, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Genetics, Genomics and Proteomics Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: CD4+ T cells dominate focal lymphocytic infiltrates in Sjögren’s disease (SjD), but their differentiation states have remained unclear. Here, we used single cell (sc)RNAseq to discover CD4+ T cell states and spatial proteomics to confirm the findings.

Methods: CD4+CD45RA– memory T cells were singly sorted from minor salivary gland biopsies of individuals meeting the 2016 ACR/EULAR criteria for SjD (n=6) and subjected to scRNAseq using SmartSeq2. Transcripts aligning to the genome with HISAT2 and expressed in >10% of cells were used for dimensionality reduction. Data from the first 10 principal components were visualized with UMAP. Gene set enrichment analysis (GSEA) was used to identify the clusters. Differentially expressed (DE) transcripts between clusters were assessed by MAST using genes expressed in >1% of cells. FFPE tissue sections from an independent set of SjD cases (n=49) and symptomatic individuals with no objective signs of SjD (n=15) were subjected to Nanostring spatial proteomic analysis, with regions of interest (ROI) segmented on CD45 or pan cytokeratin (PanCK) fluorescent signals. Data normalized to ROI area were used to evaluate relationships between proteins using Pearson’s correlations.

Results: Half of single cell cDNAs passed quality control (QC) and underwent library preparation and sequencing with PE150 reads. Of 402 sequenced cells, 385 passed QC (< 30% mitochondrial reads, avg expression >3). Clusters (CL) corresponded to central memory T helper (CL0), quiescent (CL1), activated CD4+ cytotoxic T lymphocyte (CTL) (CL2), early activated/stressed (CL3), and regulatory/T follicular helper (CL4) cells. CL0 and CL2 were enriched for CD4+ CTL precursor and effector signatures, respectively, by GSEA. Within Nanostring ROIs containing lymphocytic foci, GZMA and GZMB showed stronger correlative relationships with CD3 (r=0.724, p< 0.0001; r=0.640, p< 0.0001) compared to CD56 (r=0.462, p< 0.0001; r=0.449, p< 0.0001) in SjD cases. GZMA and GZMB were more strongly correlated with CD4 (r=0.711, p< 0.0001; r=0.512, p< 0.0001) than CD8 (r=0.523, p< 0.0001,r=0.221, p=0.003) in SjD cases. Correlations between CD4 and GZMA (r=0.432, p=0.004) or GZMB (r=0.185, p=ns) were weaker or absent in non-SS control ROIs containing lymphocytic clusters. CD4 in the CD45 segment of SjD cases correlated with markers of epithelial to mesenchymal cell transition (FAP-a) and tissue damage (CD95/Fas, PARP, BIM, p53, GZMA, GZMB) in the PanCK segment of matched ROIs, while similar relationships with CD8 were absent or weak.

Conclusion: Activated CD4+ CTL are present in minor salivary glands of SjD cases, and proteomic markers of cytotoxicity associate with CD3 and CD4 in regions containing focal infiltrates. GZMA, GZMB, and CD4 protein levels in CD45+ cells correlate with markers of tissue damage in epithelial cells near lymphocytic infiltrates, implicating CD4+ CTL in glandular pathology of SjD.


Disclosures: M. Joachims, None; C. Li, None; J. Rusbuldt, Janssen; B. Fowler, None; A. Rasmussen, None; K. Grundahl, None; R. Scofield, None; K. Sivils, Janssen Research & Development, LLC; C. Lessard, Janssen; A. Farris, Janssen.

To cite this abstract in AMA style:

Joachims M, Li C, Rusbuldt J, Fowler B, Rasmussen A, Grundahl K, Scofield R, Sivils K, Lessard C, Farris A. CD4+ Cytotoxic T Lymphocytes (CTL) Are Present in Sjögren’s Disease Minor Salivary Glands and Associate with Markers of Epithelial Cell Damage near Infiltrates [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/cd4-cytotoxic-t-lymphocytes-ctl-are-present-in-sjogrens-disease-minor-salivary-glands-and-associate-with-markers-of-epithelial-cell-damage-near-infiltrates/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd4-cytotoxic-t-lymphocytes-ctl-are-present-in-sjogrens-disease-minor-salivary-glands-and-associate-with-markers-of-epithelial-cell-damage-near-infiltrates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology